Human leukocyte antigen class I and class II genes polymorphisms might be associated with interferon α therapy efficiency of chronic hepatitis B
- 31 March 2011
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 89 (3) , 189-192
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- HLA: A Pharmacogenomics Success StoryPharmacogenomics, 2010
- Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness†Hepatology, 2005
- Influence of HLA-DRB1 alleles and HBV genotypes on interferon-α therapy for chronic hepatitis BWorld Journal of Gastroenterology, 2005
- Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patientsWorld Journal of Gastroenterology, 2005
- Characterization of HLA DR13-restricted CD4+ T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis BJournal of General Virology, 2002
- Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot studyHepatology, 2002
- HLA Class II peptide‐binding and autoimmunityTissue Antigens, 2002
- Management of hepatitis B: 2000—Summary of a workshopGastroenterology, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- The HLA SystemNew England Journal of Medicine, 2000